Dr Jennifer Juno obtained her PhD in 2014 at the University of Manitoba in Canada, where she studied immune dysfunction during chronic HIV infection. She then completed a post-doctoral fellowship at the Public Health Agency of Canada, examining the impact of TB infection on unconventional T cell subsets. She joined the lab of Dr. Stephen Kent in 2016 to study unconventional T cell immunology in macaque models of HIV infection. Most recently, she has developed a strong interest in understanding Tfh responses to viral infections or vaccination, including influenza and SARS-CoV-2.
Jennifer has been awarded a number of fellowships during her PhD and post-doctoral positions, including a NHMRC EL2 Investigator Grant in 2021. She has received both national and international funding to study unconventional T cell and Tfh responses in HIV, TB, influenza and SARS-CoV-2 infection. She has published a number of peer-reviewed publications, including recent papers in Nature Medicine, Nature Communications and JCI.